Funding
Strategic · Healthtech

IMVARIA receives strategic financing for digital biomarkers

InHealth Ventures, Labcorp Venture Fund and Cedar Crest Holdings participated in the financing.

Updated Oct 16, 2026By RoundOS Funding desk

IMVARIA received strategic financing on January 7. Participants included InHealth Ventures, Labcorp Venture Fund and Cedar Crest Holdings. Financial terms were not disclosed. The company develops AI-based digital biomarkers to support clinical diagnosis.

Funding history

Strategic · This roundUndisclosed

Sources

  1. IMVARIAprojectstartups.com
  2. businesswire.com

Similar rounds

All Healthtech rounds →
Guoke Brain-Computer

Beijing startup developing non-invasive wearable brain-computer interfaces that combine brain-signal detection, decoding and neural modulation.

UndisclosedSeed · Oct 23, 2026
Pathos AI

Clinical-stage drug developer using AI to select therapeutic assets and guide oncology trials.

$237MSeries E · Oct 23, 2026
Knowledge Work

Tokyo software company developing sales AI agents, an agent operating platform and consulting services for enterprise sales teams.

¥4.8BSeries C debt second close · Oct 23, 2026
Fairy Devices

Tokyo company developing wearable devices and remote-assistance software for industrial field workers.

UndisclosedJICN equity investment · Oct 23, 2026

Related